See the DrugPatentWatch profile for Prolia
What is “Prolia jaw necrosis” and what causes it?
“Prolia jaw necrosis” usually refers to osteonecrosis of the jaw (ONJ) that occurs in people taking Prolia (denosumab). ONJ is a condition where bone in the jaw fails to heal, often after dental stress such as tooth extraction, dental surgery, or infection. The risk is linked to drugs that reduce bone turnover; Prolia is one of those medications [1].
How common is ONJ in people taking Prolia?
Public guidance and labeling note that ONJ can occur with Prolia, but it is considered uncommon. The risk is higher in people who need invasive dental procedures and in those who have been on bone-modifying therapy for longer periods, as well as in people with cancer, poor oral hygiene, or certain other health factors [1].
Who is at higher risk?
Higher-risk situations commonly include:
- Needing tooth extraction, implants, or other invasive dental work
- Wearing dentures that irritate the mouth
- Existing gum disease or poor oral hygiene
- Longer exposure to bone-modifying drugs
- Smoking and other factors that impair healing
- Conditions like cancer or immune suppression (risk factors can overlap) [1]
What symptoms should people watch for?
People are often advised to seek dental evaluation if they notice signs such as:
- Pain, swelling, or a feeling of pressure in the jaw
- Exposed bone in the mouth
- Non-healing sores after dental work
- Loose teeth without an obvious cause
- Infection or drainage in the jaw area [1]
What should you do before starting Prolia if you need dental work?
Before starting Prolia, clinicians typically recommend a dental assessment if there is planned invasive dental treatment. If dental surgery is needed, it’s often preferable to address it before starting or early in treatment to reduce the chance of ONJ [1].
What if you already take Prolia and need a tooth extraction?
The decision is individualized. In general, people taking Prolia should involve both the prescriber and a dentist/oral surgeon before invasive procedures, because ONJ risk depends on patient factors and the timing of dental treatment relative to drug dosing [1].
Can Prolia be stopped to reduce ONJ risk?
Stopping Prolia is a complex decision because Prolia can lead to rapid bone loss and increased fracture risk if it is discontinued without a plan. Any change should be coordinated with the prescribing clinician and should not be based solely on the possibility of ONJ [1].
How is ONJ diagnosed and treated?
Diagnosis is clinical and often based on findings in the jaw and imaging when needed. Treatment depends on severity and can include:
- Local wound care and infection control
- Antibiotics in selected cases
- Pain control
- Dental management by an oral surgeon
- In some cases, surgical approaches, balanced against the risk of worsening healing problems [1]
Is ONJ treatable, and does it heal?
Some cases improve with appropriate dental/medical management, especially when caught early and managed with proper oral surgery and infection control. Severe cases can be harder to resolve, which is why prevention and early evaluation matter [1].
Does ONJ happen only with Prolia, or with other drugs too?
ONJ is also reported with other antiresorptive or bone-modifying therapies (including some other agents in the same drug class). Prolia’s labeling includes ONJ risk, along with guidance for preventing and monitoring the condition [1].
What to do now if you’re worried you have ONJ
If you suspect jaw problems while on Prolia—especially exposed bone, persistent non-healing after dental work, swelling, or drainage—the most direct next step is prompt evaluation by a dentist or oral surgeon familiar with ONJ, and coordination with your Prolia prescriber [1].
Sources
- U.S. FDA Prescribing Information for Prolia (denosumab)